Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Transfusion ; 61(1): 294-302, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33206404

RESUMO

BACKGROUND: The availability of a safe blood supply is a key component of transfusion medicine. A decade of decreased blood use, decreased payment for products, and a dwindling donor base have placed the sustainability of the US blood supply at risk. STUDY DESIGN AND METHODS: A literature review was performed for blood center (BC) and hospital disaster management, chronically transfusion-dependent diseases, and appropriate use of group O-negative red blood cells (RBCs), and the Choosing Wisely campaign. The aim was to identify current practice and to make recommendations for BC and hospital actions. RESULTS: While BCs are better prepared to handle disasters than after the 9/11 attacks, messaging to the public remains difficult, as donors often do not realize that blood transfused during a disaster was likely collected before the event. BCs and transfusion services should participate in drafting disaster response plans. Hospitals should maintain inventories adequate for patients in the event supply is disrupted. Providing specialty products for transfusion-dependent patients can strain collections, lead to increased use of group O RBCs, and create logistical inventory challenges for hospitals. The AABB Choosing Wisely initiative addresses overuse of blood components to optimally use this precious resource. Group O-negative RBCs should be transfused only to patients who truly need them. CONCLUSIONS: Collecting and maintaining a blood supply robust enough to handle disasters and transfusion-dependent patients in need of specialty products is challenging. Collaboration of all parties should help to optimize resources, ensure appropriate collections, improve patient care, and ultimately result in a robust, sustainable blood supply.


Assuntos
Transfusão de Componentes Sanguíneos/ética , Doadores de Sangue/estatística & dados numéricos , Segurança do Sangue/métodos , Medicina Transfusional/organização & administração , Sistema ABO de Grupos Sanguíneos/classificação , Sistema ABO de Grupos Sanguíneos/imunologia , Transfusão de Componentes Sanguíneos/estatística & dados numéricos , Doadores de Sangue/provisão & distribuição , Segurança do Sangue/estatística & dados numéricos , Comportamento Cooperativo , Planejamento em Desastres/legislação & jurisprudência , Eritrócitos/imunologia , Feminino , Hospitais/normas , Hospitais/estatística & dados numéricos , Humanos , Satisfação do Paciente/estatística & dados numéricos
2.
N Engl J Med ; 372(15): 1419-29, 2015 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-25853746

RESUMO

BACKGROUND: Some observational studies have reported that transfusion of red-cell units that have been stored for more than 2 to 3 weeks is associated with serious, even fatal, adverse events. Patients undergoing cardiac surgery may be especially vulnerable to the adverse effects of transfusion. METHODS: We conducted a randomized trial at multiple sites from 2010 to 2014. Participants 12 years of age or older who were undergoing complex cardiac surgery and were likely to undergo transfusion of red cells were randomly assigned to receive leukocyte-reduced red cells stored for 10 days or less (shorter-term storage group) or for 21 days or more (longer-term storage group) for all intraoperative and postoperative transfusions. The primary outcome was the change in Multiple Organ Dysfunction Score (MODS; range, 0 to 24, with higher scores indicating more severe organ dysfunction) from the preoperative score to the highest composite score through day 7 or the time of death or discharge. RESULTS: The median storage time of red-cell units provided to the 1098 participants who received red-cell transfusion was 7 days in the shorter-term storage group and 28 days in the longer-term storage group. The mean change in MODS was an increase of 8.5 and 8.7 points, respectively (95% confidence interval for the difference, -0.6 to 0.3; P=0.44). The 7-day mortality was 2.8% in the shorter-term storage group and 2.0% in the longer-term storage group (P=0.43); 28-day mortality was 4.4% and 5.3%, respectively (P=0.57). Adverse events did not differ significantly between groups except that hyperbilirubinemia was more common in the longer-term storage group. CONCLUSIONS: The duration of red-cell storage was not associated with significant differences in the change in MODS. We did not find that the transfusion of red cells stored for 10 days or less was superior to the transfusion of red cells stored for 21 days or more among patients 12 years of age or older who were undergoing complex cardiac surgery. (Funded by the National Heart, Lung, and Blood Institute; RECESS ClinicalTrials.gov number, NCT00991341.).


Assuntos
Preservação de Sangue , Procedimentos Cirúrgicos Cardíacos , Transfusão de Eritrócitos , Adulto , Idoso , Tipagem e Reações Cruzadas Sanguíneas , Transfusão de Eritrócitos/efeitos adversos , Feminino , Humanos , Análise de Intenção de Tratamento , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Mortalidade , Insuficiência de Múltiplos Órgãos/classificação , Modelos de Riscos Proporcionais , Índice de Gravidade de Doença , Fatores de Tempo
4.
Prehosp Emerg Care ; 20(5): 609-14, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26985695

RESUMO

OBJECTIVE: Test computer-assisted modeling techniques using prehospital vital signs of injured patients to predict emergency transfusion requirements, number of intensive care days, and mortality, compared to vital signs alone. METHODS: This single-center retrospective analysis of 17,988 trauma patients used vital signs data collected between 2006 and 2012 to predict which patients would receive transfusion, require 3 or more days of intensive care, or die. Standard transmitted prehospital vital signs (heart rate, blood pressure, shock index, and respiratory rate) were used to create a regression model (PH-VS) that was internally validated and evaluated using area under the receiver operating curve (AUROC). Transfusion records were matched with blood bank records. Documentation of death and duration of intensive care were obtained from the trauma registry. RESULTS: During the course of their hospital stay, 720 of the 17,988 patients in the study population died (4%), 2,266 (12.6%) required at least a 3-day stay in the intensive care unit (ICU), 1,171 (6.5%) required transfusions, and 210 (1.2%) received massive transfusions. The PH-VS model significantly outperformed any individual vital sign across all outcomes (average AUROC = 0.82), The PH-VS model correctly predicted that 512 of 777 (65.9%) and 580 of 931 (62.3%) patients in the study population would receive transfusions within the first 2 and 6 hours of admission, respectively. CONCLUSIONS: The predictive ability of individual vital signs to predict outcomes is significantly enhanced with the model. This could support prehospital triage by enhancing decision makers' ability to match critically injured patients with appropriate resources with minimal delays.


Assuntos
Transfusão de Sangue/estatística & dados numéricos , Serviços Médicos de Emergência/métodos , Mortalidade Hospitalar , Sinais Vitais , Ferimentos e Lesões/terapia , Adulto , Simulação por Computador , Feminino , Frequência Cardíaca , Humanos , Unidades de Terapia Intensiva , Tempo de Internação/estatística & dados numéricos , Masculino , Estudos Retrospectivos , Triagem , Ferimentos e Lesões/mortalidade
5.
Transfusion ; 55(6): 1331-9, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25823522

RESUMO

BACKGROUND: The Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial was a randomized clinical trial comparing survival after transfusion of two different blood component ratios for emergency resuscitation of traumatic massive hemorrhage. Transfusion services supporting the study were expected to provide thawed plasma, platelets, and red blood cells within 10 minutes of request. STUDY DESIGN AND METHODS: At the 12 Level 1 trauma centers participating in PROPPR, blood components transfused and delivery times were tabulated, with a focus on universal donor (UD) plasma management. The adequacy of site plans was assessed by comparing the bedside blood availability times to study goals and the new American College of Surgeons guidelines. RESULTS: Eleven of 12 sites were able to consistently deliver 6 units of thawed UD plasma to their trauma-receiving unit within 10 minutes and 12 units in 20 minutes. Three sites used blood group A plasma instead of AB for massive transfusion without complications. Approximately 4700 units of plasma were given to the 680 patients enrolled in the trial. No site experienced shortages of AB plasma that limited enrollment. Two of 12 sites reported wastage of thawed AB plasma approaching 25% of AB plasma prepared. CONCLUSION: Delivering UD plasma to massively hemorrhaging patients was accomplished consistently and rapidly and without excessive wastage in high-volume trauma centers. The American College of Surgeons Trauma Quality Improvement Program guidelines for massive transfusion protocol UD plasma availability are practicable in large academic trauma centers. Use of group A plasma in trauma resuscitation needs further study.


Assuntos
Transfusão de Componentes Sanguíneos , Hemorragia/terapia , Estudos Multicêntricos como Assunto/estatística & dados numéricos , Plasma , Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos , Ferimentos e Lesões/complicações , Sistema ABO de Grupos Sanguíneos/sangue , Bancos de Sangue/estatística & dados numéricos , Transfusão de Componentes Sanguíneos/estatística & dados numéricos , Preservação de Sangue , Criopreservação , Feminino , Hemorragia/etiologia , Humanos , Masculino , Ressuscitação , Fatores de Tempo , Centros de Traumatologia/estatística & dados numéricos , Estados Unidos , Armazenamento de Sangue/métodos
6.
Transfus Apher Sci ; 53(3): 386-92, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26297190

RESUMO

To identify preoperative predictors for the use of any blood component during and after orthotopic liver transplantation (OLT), we performed a retrospective analysis on 602 OLT patients who were randomly split into a training set (n = 482) and a validation set (n = 120). Hemoglobin and calculated MELD score were identified as independent predictors for blood use using bootstrap aggregation. A logistic regression model constructed using both variables showed comparable performance in the training and validation sets. Predictive scores can be obtained from a nomogram, and a score above -2.328 predicted transfusion of any blood component with a positive predictive value of 97% and 96% in the training and validation sets, respectively.


Assuntos
Transfusão de Sangue , Transplante de Fígado , Modelos Biológicos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes
7.
Ann Diagn Pathol ; 14(6): 443-6, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21074694

RESUMO

Diffuse panbronchiolitis (DPB) is an idiopathic inflammatory process involving respiratory bronchioles, largely restricted to Japanese people and associated with HLA Bw54. We report a case of idiopathic bronchiolitis with DPB features in an African American with hepatitis C virus infection, correlated with postmortem anatomic findings. The 53-year-old patient presented with shortness of breath and productive cough. Examination revealed hypercapnic respiratory failure. Lung computed tomography showed diffuse centrilobular nodules and branching linear opacities, whereas lung biopsy demonstrated diffuse peribronchiolar fibrosis and chronic inflammation with bronchiolectasis. He died 37 days postadmission. Autopsy revealed numerous bronchiolocentric nodules with bronchiolectasis and sheets of foamy macrophages in alveolar septa and spaces. This is a rare example of idiopathic bronchiolitis with features of DPB in an hepatitis C virus-infected African-American patient. Hepatitis C virus infection is known to be associated with extrahepatic pulmonary manifestations, and DPB may be one of these. Early diagnosis will allow appropriate treatment and may slow the disease progression.


Assuntos
Negro ou Afro-Americano/etnologia , Bronquiolite/etnologia , Bronquiolite/etiologia , Hepatite C/complicações , Bronquiolite/diagnóstico , Evolução Fatal , Infecções por Haemophilus/diagnóstico , Infecções por Haemophilus/etnologia , Infecções por Haemophilus/etiologia , Humanos , Pulmão/patologia , Macrófagos Alveolares/patologia , Masculino , Pessoa de Meia-Idade
8.
Am J Clin Pathol ; 149(1): 29-34, 2017 Dec 20.
Artigo em Inglês | MEDLINE | ID: mdl-29272886

RESUMO

OBJECTIVES: Inconclusive RBC antibody identification (ABID) may delay RBC crossmatch. An increased number of inconclusive ABID was observed, and an algorithm was developed to improve ABID efficiency. METHODS: RBC antibody screen (AS) and ABID were initially performed using solid-phase RBC adherence assay (SPRCA) and manual tube method. A retrospective analysis of AS and ABID results was performed pre- and postalgorithm implementation. RESULTS: The number of inconclusive ABID results decreased from 26 to six per month pre- and postimplementation, respectively. SPRCA became the primary AS method, and manual tube became the gold standard for ABID. SPRCA was used for ABID upon reference specialist secondary review and allowed identification of 30 specific RBC antibodies, for which no patients developed signs or symptoms of a hemolytic transfusion reaction. CONCLUSIONS: RBC reference workflow using SPRCA and manual tube methods for AS and ABID decreases "inconclusive" ABID without adverse events.


Assuntos
Algoritmos , Anticorpos/sangue , Tipagem e Reações Cruzadas Sanguíneas/métodos , Eritrócitos/imunologia , Transfusão de Eritrócitos , Humanos , Estudos Retrospectivos , Reação Transfusional , Fluxo de Trabalho
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA